Neuraly
- Website
- neuralymed.com
- Total Funding
- $36.0M
- Last Round
- $36.0M Series AJul 2018
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Neuraly is a Biotech company. It has raised $36.0M in total across 1 round, most recently a $36.0M Series A round in Jul 2018. Investors include Octave Life Sciences, Smilegate Investment and InterVest Capital Partners.
Funding History
Jul 2018
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/neuraly"><img src="https://indexed.vc/api/badge/company/neuraly" alt="Neuraly on Indexed.vc" width="260" height="76" /></a>